NEW YORK, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC), the global leader in virtual care, today announced the appointment of Michael Smith to its board of directors. With more than three decades of leadership experience in financial management and strategic transformation, Mr. Smith brings a deep understanding of long-term business sustainability within highly regulated, global markets. He joins the board following the previously announced retirements of Eric Evans and Thomas McKinley and ...

Core Viewpoint - Teladoc Health Inc. is set to release its fourth quarter 2025 results on February 25, 2026, after market close, followed by a conference call to discuss the results [1]. Group 1: Conference Call Details - The conference call will be accessible by dialing 1-833-470-1428 for U.S. participants, with an access code of 330912 [2]. - International participants can find global dial-in numbers through a provided link [2]. - A live audio webcast will be available online for the conference call [2]. Group 2: Replay Information - A replay of the conference call will be available via webcast shortly after the call concludes and will remain accessible for approximately 90 days [3]. Group 3: Company Overview - Teladoc Health is recognized as the global leader in virtual care, focusing on transforming virtual care into a catalyst for improved health outcomes [4]. - The company collaborates with health plans, employers, providers, health systems, and consumers to enhance access, drive better outcomes, extend provider capacity, and reduce costs [4].

Transforming how better health happens J.P. Morgan Healthcare Conference January 2026 Safe Harbor This presentation contains, and the officers of Teladoc Health, Inc. (the "Company" or "Teladoc Health") may make, "forward-looking" statements that are based on management's beliefs and assumptions and on information currently available to management. These forward-looking statements include, without limitation, information concerning possible or assumed future results of operations, including descriptions of ...

Core Insights - Arbiter, a startup founded by Michelle Carnahan, has raised $52 million in seed funding to create a platform that connects healthcare professionals and payers to enhance patient care [1][2] - The funding has been sourced from family offices, leading to a valuation of $400 million for Arbiter [2] - Arbiter aims to utilize AI to streamline interactions among payers, providers, and patients, with over 1,000 clinicians already engaged within six months of its launch [5] Company Background - Michelle Carnahan has extensive experience in healthcare, having worked at Eli Lilly for 26 years and later at Thirty Madison, where she played a key role in achieving a $1 billion valuation [3] - Thirty Madison was acquired by Remedy Meds in a $500 million all-stock deal in September [3] Funding Strategy - Carnahan intentionally chose to raise funds from specialized investors rather than traditional venture capital to expedite the product's market entry [4] - The partnership with family offices and the acquisition of SecondWave Delivery Systems have been pivotal in accelerating Arbiter's market presence [5][6] Mission and Vision - Arbiter's mission is to transform the U.S. healthcare system by aligning payers and providers to create a cohesive system that prioritizes patient needs [7]

Core Insights - Teladoc Health announced the resignation of Chief Financial Officer Mala Murthy, who will leave the company on November 21, 2025, to pursue an opportunity outside the healthcare industry [1][2] - The company reaffirmed its full-year 2025 consolidated revenue and adjusted EBITDA outlook, with preliminary results for Q3 2025 showing consolidated revenue of $626.4 million and adjusted EBITDA of $69.9 million [3][5] Leadership Changes - Mala Murthy will continue in her role until her departure and will present during the company's Q3 earnings conference call [2] - An interim leadership structure will be established during the search for a new CFO, with key finance leaders reporting to CEO Chuck Divita [2][3] Financial Performance - For the three months ended September 30, 2025, Teladoc Health reported a consolidated revenue of $626.4 million and an adjusted EBITDA of $69.9 million [3][18] - The adjusted EBITDA for the same period reflects a decrease from $83.3 million in Q3 2024, indicating a year-over-year decline [18] Upcoming Events - The company will host a conference call on October 29, 2025, to discuss its Q3 2025 financial results, with a news release and presentation materials to be issued prior to the call [4]

Core Insights - Teladoc Health Inc. will release its third quarter 2025 results on October 29, 2025, after market close [1] - A conference call to discuss the results will take place at 5:00 p.m. ET on the same day [1] Conference Call Details - U.S. participants can access the conference call by dialing 1-833-470-1428 with access code 609817 [2] - International participants can find global dial-in numbers through a provided link [2] - A live audio webcast will be available online for those who prefer to listen via the internet [2] Replay Information - A replay of the conference call will be available shortly after its completion and will remain accessible for approximately 90 days [3] Company Overview - Teladoc Health is recognized as the global leader in virtual care, focusing on delivering and orchestrating care across various stakeholders [4] - The company aims to enhance access, improve health outcomes, extend provider capacity, and reduce costs through its extensive relationships with health plans, employers, providers, health systems, and consumers [4]

Group 1 - The company reported a 49% increase in revenue for Q2, reaching $61 million compared to $41.21 million a year earlier, exceeding analysts' expectations of $55.2 million [1][3] - The net loss for the quarter was $5.31 million, translating to a loss of 24 cents per share, an improvement from a net loss of $10.69 million or $1.40 loss per share in the same period last year [1][3] - CEO Sean Duffy highlighted the company's ability to capitalize on trends in cardiometabolic care and advancements in artificial intelligence as key factors in their performance [2]

Core Points - Teladoc Health Inc. will release its second quarter 2025 results on July 29, 2025, after market close [1] - A conference call to discuss the results will take place at 4:30 p.m. ET on the same day [1] - The company is recognized as a global leader in virtual care, aiming to transform healthcare experiences [4] Conference Call Details - U.S. participants can access the conference call by dialing 1-833-470-1428 with access code 606269 [2] - International participants can find global dial-in numbers through a provided link [2] - A live audio webcast will be available online for those who prefer to listen via the internet [2] Replay Information - A replay of the conference call will be available shortly after its completion for on-demand listening [3] - The replay will remain accessible for approximately 90 days [3] Company Overview - Teladoc Health empowers individuals to live healthier lives by enhancing the healthcare experience [4] - The company utilizes proprietary health signals and personalized interactions to improve health outcomes [4] - With over two decades of expertise, Teladoc Health addresses the increasing virtual care needs of consumers and healthcare professionals [4]